All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practiceJuan Berenguer, Juan González‐García, Ángela Gil‐Martin et al.|Hepatology|2018Cited by 79
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort studySergio Serrano‐Villar, Ignacio de los Santos, Joaquín Portilla et al.|The Lancet HIV|2020Cited by 70
Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individualsJuan Berenguer, Juan González‐García, Ángela Gil‐Martin et al.|AIDS|2018Cited by 58
HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1Juan Berenguer, Juan González‐García, José Luís Calleja et al.|Open Forum Infectious Diseases|2019Cited by 4